These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33178612)
1. Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy. Meng Y; Luo W; Wang W; Zhou C; Zhou S; Tang X; Hou L; Kong FS; Yang H Front Oncol; 2020; 10():584756. PubMed ID: 33178612 [TBL] [Abstract][Full Text] [Related]
2. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients. Meng Y; Yang H; Wang W; Tang X; Jiang C; Shen Y; Luo W Radiat Oncol; 2019 Jan; 14(1):7. PubMed ID: 30642354 [TBL] [Abstract][Full Text] [Related]
3. Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients. Ye F; Xu L; Ren Y; Xia B; Chen X; Ma S; Deng Q; Li X Front Oncol; 2024; 14():1343170. PubMed ID: 38357195 [TBL] [Abstract][Full Text] [Related]
4. Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning. Wang W; Xu Y; Schipper M; Matuszak MM; Ritter T; Cao Y; Ten Haken RK; Kong FM Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):956-63. PubMed ID: 23845844 [TBL] [Abstract][Full Text] [Related]
5. Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapy. Abe T; Iino M; Saito S; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Miura Y; Kaira K; Kagamu H; Noda S; Kato S Thorac Cancer; 2022 Oct; 13(20):2890-2896. PubMed ID: 36054298 [TBL] [Abstract][Full Text] [Related]
6. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy]. Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300 [TBL] [Abstract][Full Text] [Related]
7. Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy. Lan K; Zhu J; Zhang J; Zhou S; Yang Y; Feng Z; Zhang L; Wang S; Xi M Radiother Oncol; 2020 Aug; 149():228-235. PubMed ID: 32474127 [TBL] [Abstract][Full Text] [Related]
8. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162 [TBL] [Abstract][Full Text] [Related]
9. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis. Uchida Y; Tsugawa T; Tanaka-Mizuno S; Noma K; Aoki K; Shigemori W; Nakagawa H; Kinose D; Yamaguchi M; Osawa M; Ogawa E; Nakano Y Radiat Oncol; 2017 Oct; 12(1):160. PubMed ID: 28969651 [TBL] [Abstract][Full Text] [Related]
10. Adaptive intensity-modulated radiotherapy with simultaneous integrated boost for stage III non-small cell lung cancer: Is a routine adaptation beneficial? Meng Y; Luo W; Xu H; Wang W; Zhou S; Tang X; Li Z; Zhou C; Yang H Radiother Oncol; 2021 May; 158():118-124. PubMed ID: 33636232 [TBL] [Abstract][Full Text] [Related]
11. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Piotrowski T; Matecka-Nowak M; Milecki P Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028 [TBL] [Abstract][Full Text] [Related]
12. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy. Khalil AA; Hoffmann L; Moeller DS; Farr KP; Knap MM Acta Oncol; 2015; 54(9):1343-9. PubMed ID: 26198657 [TBL] [Abstract][Full Text] [Related]
13. Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis. Kabolizadeh P; Kalash R; Huq MS; Greenberger JS; Heron DE; Beriwal S Am J Clin Oncol; 2015 Aug; 38(4):401-4. PubMed ID: 24064747 [TBL] [Abstract][Full Text] [Related]
14. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation. Ren C; Ji T; Liu T; Dang J; Li G Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254 [TBL] [Abstract][Full Text] [Related]
15. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795 [TBL] [Abstract][Full Text] [Related]
16. Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer. Zhao Y; Chen L; Zhang S; Wu Q; Jiang X; Zhu H; Wang J; Li Z; Xu Y; Zhang YJ; Bai S; Xu F Thorac Cancer; 2015 Jan; 6(1):49-57. PubMed ID: 26273335 [TBL] [Abstract][Full Text] [Related]
17. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT). Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504 [TBL] [Abstract][Full Text] [Related]
18. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313 [TBL] [Abstract][Full Text] [Related]
19. Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design. Moiseenko V; Grimm J; Yorke E; Jackson A; Yip A; Huynh-Le MP; Mahadevan A; Forster K; Milano MT; Hattangadi-Gluth JA Cureus; 2020 Oct; 12(10):e10808. PubMed ID: 33163312 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors. Zhang X; Yang D; Jiang Y; Huang L; Wang C; Tao D; Liu X; Lei Y; Wu Y; Zhou W J Inflamm Res; 2021; 14():4205-4215. PubMed ID: 34483676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]